Growth Metrics

Bio Key International (BKYI) Liabilities and Shareholders Equity (2016 - 2025)

Bio Key International's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $10.1 million for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 58.03% year-over-year to $10.1 million; the TTM value through Sep 2025 reached $40.4 million, up 103.32%, while the annual FY2024 figure was $8.6 million, 90.73% up from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $10.1 million at Bio Key International, down from $10.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $21.5 million in Q1 2021 and bottomed at $4.2 million in Q1 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $10.5 million (2025), against an average of $12.0 million.
  • The largest annual shift saw Liabilities and Shareholders Equity soared 611.53% in 2021 before it plummeted 60.41% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $17.8 million in 2021, then tumbled by 36.16% to $11.3 million in 2022, then plummeted by 60.18% to $4.5 million in 2023, then skyrocketed by 90.73% to $8.6 million in 2024, then rose by 17.38% to $10.1 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Liabilities and Shareholders Equity are $10.1 million (Q3 2025), $10.5 million (Q2 2025), and $11.2 million (Q1 2025).